Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours

Cancer immunotherapies including immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR) T-cell therapy have shown variable response rates in paediatric patients highlighting the need to establish robust biomarkers for patient selection.